Artificial Intelligence (AI) is one of the technologies that has evolved the most in recent years and its application has increased exponentially.
The VI Edition of the Young Researchers Awards, launched by the AstraZeneca Foundation and the Carlos III Health Institute, has extended the deadline for receipt of applications until next Wednesday, 28 September.
ICE and AIR Institute organise conferences on innovation and cybersecurity as part of the Centr@tec Programme
The Institute for Business Competitiveness of Castilla y León (ICE) in collaboration with Air Institute are organising several activities within the framework of the Centr@Tec Programme for SMEs, startups and entrepreneurs attending the 8th Startup Olé event in Salamanca.
DISGIS3, the consortium led by AIR Institute along with the Institute for Business Competitiveness of Castilla y León (ICE), DIHBU, the DIH-LEAF, the Castilla y León Supercomputing Foundation (SCAYLE) and the University of León, will have access to a European budget for the promotion of digitisation in the region.
Soon the 8th Startup OLÉ event will take place. The BISITE Research Group and AIR Institute will take part in the event to showcase its national and international projects. From 5 to 7 September, Salamanca will host, as every year, one of the biggest events of entrepreneurship, innovation and investors held in Spain.
The IoTalentum project in which the BISITE Research Group participates continues to achieve its objectives. The project is a Marie Skłodowska-Curie Horizon 2020 European Training Network on the Internet of Things.
The C1b3rWall Academy 2021/22 project organised by the National Police and the BISITE Research Group has been highly successful. We have managed to bring together more than 40 thousand participants who, for the past year, […]
The Centr@tec programme presents PERTE Vanguard Health to a hundred representatives from the health sector
Today, the ” PERTE Vanguard Health in Castilla y León” conference took place. Colegio Fonseca hosted a hundred representatives from companies, institutions and the general public to learn about the characteristics of this project whose main objective is to position Spain as a leading country in the innovation and development of advanced therapies for the cure of diseases such as diabetes or ALS.